PP

Patricia Parra

Human Resources Generalist at Comprehensive Cancer Centers of Nevada

Patricia Parra, SHRM-CP, is an experienced Human Resources professional with a background in talent acquisition, employee orientation, and payroll administration. Patricia has held various roles in HR and management, including Assistant Manager, HR Associate, and Paralegal. With a Bachelor's Degree in Business Administration, Patricia is skilled in recruitment, training, and maintaining compliance with licensure and certification requirements. Throughout their career, Patricia has shown a strong commitment to supporting employees and ensuring efficient HR operations.

Location

Henderson, United States

Links


Org chart

No direct reports

Teams


Offices


Comprehensive Cancer Centers of Nevada

Comprehensive Cancer Centers of Nevada is the award-winning multi-specialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research with treatment centers and offices throughout Southern Nevada. Comprehensive has provided oncology services to Southern Nevada residents and visitors for more than 40 years. The practice’s specialized physician and nursing staff offers sophisticated diagnostic tools, the latest advances in cancer treatment, a full range of innovative, exclusive services and research-based care in a supportive and caring environment. In order to provide patients the most progressive and effective cancer treatments, Comprehensive expanded its clinical research program by partnering with some of the world’s most recognizable research and cancer-fighting organizations. In 1995, Comprehensive physicians became part of The US Oncology Network, one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Today, Comprehensive participates in more than 170 Phase I, Phase II and Phase III clinical research studies each year, and has helped develop more than 100 FDA approved cancer therapies including approvals for Hercepin, Provenge, TECENTRIQ®, Xofigo, Keytruda and others.


Employees

501-1,000

Links